# Max India Ltd (MAXIND)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹157.59
Day Change: +1.37%
52W High: ₹241.57
52W Low: ₹120
Market Cap: ₹823 Cr

## Valuation
P/E: 0
P/B: 1.75
EPS: ₹-29.76
Book Value: ₹89.4
Dividend Yield: 0%

## Returns
1Y Return: -23.2%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0.44
Revenue Growth: 27.4%
Profit Growth: 0%
EBITDA Margin: -63.08%
Operating Margin: -59.39%

## About
Max India Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Max India Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Announcement under Regulation 30 (LODR)-Change in Directorate
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:59:11.886Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:11.886Z
Quant Updated: 2026-05-18T22:59:11.886Z
Sentiment Updated: 2026-05-18T22:59:11.886Z
Financials Status: current
Financials Updated: 2026-05-19T12:30:58.521Z
Financials Last Attempt: 2026-05-19T12:30:58.521Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹145.49 Cr
Operating Profit: ₹-134.09 Cr (OPM -92.16%)
Net Profit: ₹-140.39 Cr
Tax: ₹1.81 Cr

## Annual P&L History
FY25: Rev ₹145.49Cr | PAT ₹-140.39Cr | OPM -92.16%
FY24: Rev ₹175.63Cr | PAT ₹-56.38Cr | OPM -34.99%
FY23: Rev ₹201.03Cr | PAT ₹-10.38Cr | OPM 0.17%

## Balance Sheet (FY25)
Total Assets: ₹632.85 Cr
Total Liabilities: ₹274.16 Cr
Borrowings: ₹102.3 Cr
Cash: ₹22.7 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Analjit  Singh BA, BS, MBA, Founder & Non-Executive Chairman
- Rajit  Mehta, MD & Director
- Sandeep  Pathak, CFO & Head of Legal
- Simardeep  Kaur, Chief Human Resource Officer
- Ajay  Agrawal, Head of Investor Relations

---
Source: rupiya.io/stocks/maxind
Disclaimer: For research and education only. Not investment advice.